New Warning for the Multiple Sclerosis Drug Alemtuzumab.
作者信息
Aschenbrenner Diane S
机构信息
Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch:
出版信息
Am J Nurs. 2019 Mar;119(3):21. doi: 10.1097/01.NAJ.0000554033.89582.5d.
Abstract
摘要
相似文献
1
New Warning for the Multiple Sclerosis Drug Alemtuzumab.多发性硬化症药物阿仑单抗的新警告
Am J Nurs. 2019 Mar;119(3):21. doi: 10.1097/01.NAJ.0000554033.89582.5d.
2
Immune-Mediated Hepatitis Induced by Therapy With Alemtuzumab in a Patient With Multiple Sclerosis.利妥昔单抗治疗多发性硬化症患者所致免疫介导性肝炎
Hepatology. 2021 Jan;73(1):460-463. doi: 10.1002/hep.31435. Epub 2020 Dec 14.
3
Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing-remitting multiple sclerosis.阿仑单抗治疗复发缓解型多发性硬化症后发生的急性后部多灶性鳞状色素上皮病变
J Neurol. 2019 Jun;266(6):1539-1540. doi: 10.1007/s00415-019-09288-y. Epub 2019 Mar 20.
4
Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab.用阿仑单抗治疗的多发性硬化症患者的中性粒细胞减少症
JAMA Neurol. 2017 Sep 1;74(9):1143-1144. doi: 10.1001/jamaneurol.2017.1456.
5
Autoimmune storm following alemtuzumab.阿仑单抗治疗后发生的自身免疫风暴。
BMJ Case Rep. 2022 Jun 27;15(6):e248037. doi: 10.1136/bcr-2021-248037.
6
Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab.用阿仑单抗治疗复发型多发性硬化症后出现的肿胀性脱髓鞘病变。
Neurology. 2017 Mar 7;88(10):1004-1006. doi: 10.1212/WNL.0000000000003694. Epub 2017 Feb 8.
7
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity.主效应：阿仑单抗相关甲状腺自身免疫的挑战性并发症
J Endocrinol Invest. 2020 Aug;43(8):1159-1161. doi: 10.1007/s40618-020-01204-w. Epub 2020 Mar 4.
8
Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature.阿仑单抗治疗多发性硬化症后早期出现中性粒细胞减少伴血小板减少：病例报告及文献复习
Clin Neurol Neurosurg. 2018 Dec;175:134-136. doi: 10.1016/j.clineuro.2018.11.002. Epub 2018 Nov 3.
9
Alemtuzumab-associated diffuse alveolar damage - a case report.阿仑单抗相关性弥漫性肺泡损伤-1 例报告。
BMC Neurol. 2020 Sep 23;20(1):357. doi: 10.1186/s12883-020-01934-7.
10
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.阿仑单抗治疗复发型多发性硬化症后发生的急性呼吸窘迫综合征
Mult Scler Relat Disord. 2017 May;14:1-3. doi: 10.1016/j.msard.2017.03.001. Epub 2017 Mar 12.
引用本文的文献
1
Risk of stroke under disease modifying therapies for multiple sclerosis: a systematic review.多发性硬化症疾病修正疗法下的中风风险：一项系统评价。
Ther Adv Neurol Disord. 2025 May 21;18:17562864251321669. doi: 10.1177/17562864251321669. eCollection 2025.
Zotero 插件